companies

Hypervision Surgical

Founded 2020
Employees 15+
Primary contact
85 Great Portland Street
First Floor
W1W 7LT London
United Kingdom
Links
https://hypervisionsurgical.com/
Sections
Technologies
A spin-out from King's College London, Hypervision Surgical aims to equip clinicians with advanced computer-assisted tissue analysis for improved surgical precision and patient safety. The company's technology relies on hyperspectral imaging, which is a safe, non-contact and non-invasive optical imaging modality ideally suited for the clinic. By splitting light into multiple spectral bands far beyond the traditional red/green/blue colors that the naked eye can see, hyperspectral imaging carries diagnostic information about tissue properties ideal for objective tissue characterization. Hypervision Surgical also uses AI for its intraoperative imaging system that seamlessly integrates into the surgical workflow and can provide wide-field real-time data-driven tissue characterization. This will objectively enhance the surgeon's ability to visualize and characterize tissue intraoperatively without injecting any contrast agents. In addition, the system can monitor vital physiological tissue properties.
Founded 2020
Employees 15+
Primary contact
85 Great Portland Street
First Floor
W1W 7LT London
United Kingdom
Links
https://hypervisionsurgical.com/
Sections
Technologies

Funding 💰

Total £6.5M
Last round 🔗 £6.5M
Seed
June 1, 2023.
Select investors Life Extension (LifeX) Ventures, HERAN Partners, Redalpine, ZEISS Ventures, MedTech Innovator

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • The clinical need: Better intraoperative guidance can help reduce patient morbidity and healthcare costs across surgical specialties. To that end, Hypervision Surgical offers detailed real-time and wide-field tissue information, non-contact measurement, and a no-contrast agent to prevent side effects.
  • Safe optical imaging: Hypervision Surgical's approach is non-contact, non-invasive and does not require any exogenous contrast agent. It relies on the safe application of light alone.
  • Quantitative AI imaging: Using AI, the company provides quantitative, wide-field information on physiological tissue properties, including perfusion assessment of tissue and blood vessels.
  • Tissue differentiation: The system is capable of AI-driven, wide-field tissue differentiation to identify the tumor, normal tissue, nerves and blood vessels in real time.

Video ▶️

In the news 📰

Hypervision Surgical raises £6.5 million to redefine surgical imaging
June 3, 2023

Awards & Recognitions 🏆

  • 2023 Cutlers' Surgical Prize 🔗

Quotes 💬

“
Hypervision Surgical's hardware-agnostic solution has the potential to redefine the standard of care in surgical imaging across various procedures, from open to minimally invasive, robotics, and microscopic surgeries.
— Raf Roelands, Investment Director at HERAN Partners 🔗
“
Hypervision Surgical's objective tissue characterisation and analytics platform is uniquely positioned to drive surgical decision-making and address critical unmet needs in the growing field of minimally invasive surgery, which sees nearly 200 million procedures annually.
— Daniel Dillinger, Investment Manager at Redalpine 🔗
“
The innovation in AI-powered vision systems, with simplified deployment in hospitals, holds the key to significantly improving the lives of millions of patients undergoing critical surgeries. Hypervision Surgical has the necessary ingredients to lead in this category.
— Iñaki Berenguer, Founding Partner at LifeX Ventures 🔗
Last update: June 13, 2023